Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

MLA

E. Monteagudo-Gimeno, et al. “Association between Depressive and Anxious Symptoms with Cognitive Function and Quality of Life in Drug-Resistant Epilepsy.” Heliyon, vol. 9, no. 10, Oct. 2023. EBSCOhost, https://doi.org/10.1016/j.heliyon.2023.e20903.

APA

E. Monteagudo-Gimeno, R. Sánchez-González, J. Raduà-Castaño, L. Fortea-González, T. Boget-Llucià, M. Carreño-Martínez, A. Donaire-Pedraza, N. Bargalló-Alabart, X. Setoain-Perego, J. Rumià-Arboix, A. Bulbena-Vilarrasa, & L. Pintor-Pérez. (2023). Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy. Heliyon, 9(10). https://doi.org/10.1016/j.heliyon.2023.e20903

Chicago

E. Monteagudo-Gimeno, R. Sánchez-González, J. Raduà-Castaño, L. Fortea-González, T. Boget-Llucià, M. Carreño-Martínez, A. Donaire-Pedraza, et al. 2023. “Association between Depressive and Anxious Symptoms with Cognitive Function and Quality of Life in Drug-Resistant Epilepsy.” Heliyon 9 (10). doi:10.1016/j.heliyon.2023.e20903.